chartexchange

OVID
Ovid Therapeutics Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:58 PM EST
2.25USD+1.351%(+0.03)2,155,305
After-hoursNov 18, 2026 4:08:30 PM EST
2.30USD+2.222%(+0.05)
Loading…
Loading…
425.59M
Healthcare
Biotechnology
CEO
Jeremy Levin
HQ
New York, NY, USA
Previous Close
$2.22
Beta
1.46
52-Week High
$3.11 2026-04-09
52-Week Low
$1.21 2025-11-20
SMA 50
$2.48
SMA 200
$2.42
Avg. Vol 10D
2.95M
Avg. Vol 30D
2.33M
Avg. Vol 90D
1.83M
Relative Vol
0.92
188.73M
156.82M
18,134,225
0.4100%
2,800,000
17,077
OVID Profile

ovid therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. ovid's drug candidate, ov101, is currently in development for the treatment of symptoms of angelman syndrome and fragile x syndrome. ovid is also developing ov935 in collaboration with takeda pharmaceutical company limited for the treatment of rare epileptic encephalopathies. ovid has initiated the phase 2 stars trial of ov101 in adults with angelman syndrome and a phase 1 trial in adolescents with angelman and fragile x syndrome to identify doses suitable for younger patients. review our community guidelines: http://www.ovidrx.com/community-guidelines/

OVID Performance
PeriodPriceDateChangeBeta
1W2.552026-11-12-11.57%4.358
1M2.172026-10-19+3.92%2.411
3M2.932026-08-19-23.04%2.138
6M2.402026-05-19-6.04%1.527
1Y1.282025-11-19+76.17%1.464
2Y1.032024-11-19+118.93%—
5Y3.442021-11-19-34.45%1.017
OVID Stock Summary

Ovid Therapeutics Inc. Common Stock (NASDAQ:OVID) stock price today is $2.26, and today's volume is 2,155,305. OVID is up 1.577% today. The 30 day average volume is 2.33M. OVID market cap is $425.59M with 188.73M shares outstanding.